Healthcare Stocks Present Potential Bargains Amid Market Uncertainty

As stock market volatility persists, several healthcare companies are exhibiting strong financial indicators and potential for growth, offering investors possible opportunities for value.

Dialysis center operator DaVita (DVA) has seen its share price decline approximately 14% this year, influenced by factors including quarterly earnings reports, a ransomware attack, and adjustments by significant shareholder Berkshire Hathaway. However, analysts note that Berkshire’s selling is largely due to a pre-existing shareholder agreement involving share repurchases by DaVita, and the company’s international expansion alongside its stable U.S. business suggests potential for improved future earnings. Currently trading at a forward price-to-earnings ratio of 11, DaVita’s valuation could increase. Investors often seek companies with solid fundamentals during times of economic uncertainty, and healthcare is frequently considered a defensive sector.

Pharmaceutical giant Merck (MRK) is currently valued at just 9 times forward earnings, largely due to concerns surrounding the 2028 patent expiration of its blockbuster cancer drug, Keytruda. However, the company is proactively addressing this challenge with the launch of Keytruda Qlex, a subcutaneous version, and a robust pipeline of 20 potential blockbuster drugs representing $50 billion in potential revenue. A successful mitigation of Keytruda patent concerns could lead to a re-rating of the stock to a valuation more in line with its peers. For more information on pharmaceutical patent expirations, see this report from the Food and Drug Administration.

Universal Health Services (UHS), a provider of acute and behavioral healthcare services, is also trading at a discount compared to similar hospital operators, with a forward earnings multiple of 9 compared to Tenet Healthcare’s 13 and HCA Healthcare’s 15. Analysts suggest that continued earnings growth, coupled with a potential re-rating, could drive the stock higher. Understanding the American Hospital Association’s current outlook can provide further context on the healthcare industry’s performance.

Company officials indicated they will continue to monitor market conditions and pursue strategies to maximize shareholder value.